Loading clinical trials...
Loading clinical trials...
Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy With Peripheral Autologous Stem Cell Reinfusion in Patients With Hematological Neoplasms and Solid Tumors: Phase II Randomised Trial
Conditions
Interventions
Filgrastim
Pegfilgrastim
Locations
1
Italy
Istituto Clinico Humanitas
Rozzano, Milan, Italy
Start Date
September 1, 2006
Primary Completion Date
November 1, 2008
Completion Date
November 1, 2008
Last Updated
July 1, 2013
NCT06898450
NCT01247597
NCT06658951
NCT05101070
NCT06625775
NCT05719558
Lead Sponsor
Armando Santoro, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions